Skip to main content
Advertisement
Advertisement

NPCE

NPCE logo

Neuropace, Inc. Common Stock

14.04
USD
Sponsored
+0.17
+1.23%
Sep 11, 15:59 UTC -4
Closed
exchange

After-Market

14.42

+0.38
+2.71%

NPCE Earnings Reports

Positive Surprise Ratio

NPCE beat 15 of 22 last estimates.

68%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$27.64M
/
-$0.10
Implied change from Q2 26 (Revenue/ EPS)
+21.07%
/
-44.44%
Implied change from Q3 25 (Revenue/ EPS)
+1.03%
/
-9.09%

Neuropace, Inc. Common Stock earnings per share and revenue

On Aug 11, 2026, NPCE reported earnings of -0.18 USD per share (EPS) for Q2 26, beating the estimate of -0.21 USD, resulting in a 16.47% surprise. Revenue reached 22.83 million, compared to an expected 23.11 million, with a -1.22% difference. The market reacted with a -3.26% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 27.64 million USD, implying an decrease of -44.44% EPS, and increase of 21.07% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NANO-X IMAGING LTD Ordinary Shares
Report Date
Sep 09, 2026 For Q2 26
Estimate
-$0.16
Actual
-$0.79
Surprise
-374.19%
FAQ
For Q2 2026, Neuropace, Inc. Common Stock reported EPS of -$0.18, beating estimates by 16.47%, and revenue of $22.83M, -1.22% below expectations.
The stock price moved down -3.26%, changed from $15.05 before the earnings release to $14.56 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 9 analysts, Neuropace, Inc. Common Stock is expected to report EPS of -$0.10 and revenue of $27.64M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement